Association of sex hormone-binding globulin and dyslipidemia with Japanese postmenopausal women: a cross-sectional study
- PMID: 40495241
- PMCID: PMC12150563
- DOI: 10.1186/s12944-025-02634-2
Association of sex hormone-binding globulin and dyslipidemia with Japanese postmenopausal women: a cross-sectional study
Abstract
Background: In postmenopausal women, lower levels of sex hormone-binding globulin (SHBG) have been linked to various metabolic conditions. The association between SHBG levels and the presence of dyslipidemia was investigated in comparison with other sex hormones.
Methods: Data from 570 postmenopausal women were analyzed. To assess the relationship between circulating sex hormone concentrations and dyslipidemia, logistic regression and receiver operating characteristic (ROC) curve analyses were performed to assess the relationships.
Results: Participants had a median age of 51.0 years (49.0-53.0). The multivariate analysis revealed that SHBG levels were significantly associated with dyslipidemia. Specifically, low SHBG levels correlated with hypertriglyceridemia and low high-density lipoprotein levels. The area under the curve (AUC) and the optimal SHBG level cutoff value for identifying the presence of dyslipidemia were 0.626 and 69.0 nmol/L, respectively. The AUCs for SHBG levels were highest for estradiol (E2), total testosterone (TT) and dehydroepiandrosterone sulfate (DHEAS) levels.
Conclusions: SHBG levels were significantly associated with dyslipidemia in postmenopausal women and outperformed E2, TT, and DHEAS levels. These findings highlight SHBG as a potential biomarker for dyslipidemia risk in postmenopausal women, warranting further research into its prognostic utility.
Keywords: Cohort; Dyslipidemia; Japanese; Menopause; Sex hormone-binding globulin (SHBG).
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval: The present study was approved by the Institutional Ethics Committee of the Kyoto Prefectural University of Medicine (approval number: ERB-C-3202 at 2024) and was conducted in accordance with the Declaration of Helsinki. Competing interests: The authors declare no competing interests.
Figures
References
-
- Pirillo A, Casula M, Olmastroni E, Norata GD, Catapano AL. Global epidemiology of dyslipidaemias. Nat Rev Cardiol. 2021;18:689–700. - PubMed
-
- Yusuf S, Hawken S, Ôunpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937–52. - PubMed
-
- El Khoudary SR, Aggarwal B, Beckie TM, Hodis HN, Johnson AE, Langer RD, Limacher MC, Manson JE, Stefanick ML, Allison MA. Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American Heart Association. Circulation. 2020;142:E506–32. - PubMed
-
- Lamberts SWJ, van den Beld AW, van der Lely A-J. The endocrinology of aging. Sci (1979). 1997;278:419–24. - PubMed
-
- Pasquali R, Vicennati V, Bertazzo D, Casimirri F, Pascal G, Tortelli O, Labate AMM. Determinants of sex hormone—binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Metabolism. 1997;46:5–9. - PubMed
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Miscellaneous
